Medicare will start covering obesity drugs for the first time. Here’s what patients should know
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity …
Business
As the largest World Cup ever kicks off, health officials are focused on more than Ebola
As athletes and millions of fans gear up for the FIFA World Cup starting next week, global health officials are …
Hantavirus outbreak isn’t another Covid pandemic – but experts say it’s testing U.S. readiness
A cruise ship outbreak of hantavirus has rattled the public and reignited fears of another global health scare as passengers …
Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era
Boxes of medication are seen on the shelves of the Keencare pharmacy, a member of the Green Light Group, on …
Novo Nordisk’s explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment
After years of trying to lose weight “the right way,” Jane Zuckerman realized that “putting in the work just wasn’t …
The price of menstrual products is skyrocketing from inflation, tariffs
Always products are displayed on a shelf in a supermarket in Sarajevo, Bosnia and Herzegovina October 29, 2024. Dado Ruvic …
GLP-1 drugs are changing how Americans eat. Food companies are racing to catch up
A mini burger, mini fries and mini beer, Clinton Hall’s “Teeny Weeny Mini Meal”, is pictured next to a regular-sized …
Inside the booming business of wellness third spaces and membership clubs
A few years ago, Grace Guo began to crave places in New York City where hanging out with friends didn’t …
Three decades into cystic fibrosis fight, Boomer Esiason and his son Gunnar are winning
As NFL quarterback Boomer Esiason was about to step onto the practice field for the New York Jets in 1993, …
Novo Nordisk faces a defining year in the obesity drug market. It’s off to a dramatic start
Mike Doustdar, CEO of Novo Nordisk, speaks in the Oval Office during an event about weight loss drugs at the …